BioTelemetry (BEAT) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/10/2026
- Wall St dips as tech declines, Middle East tensions mount
- Oil prices rise after Trump says Iran must pay price
- Oracle reports earnings today: Analysts say this metric could 'catalyze higher multiples'
- UBS sees generational semiconductor boom, highlights stock winners
- Has Tesla solved the self-driving puzzle? This analyst thinks so
- Hut 8 Mining Corp. (HUT) PT Raised to $55 at KBW As Management Delivers
- Micron to deliver 'another strong quarter', Goldman says
- Needham Starts Hyliion Holdings (HYLN) at Buy
- UK's Ofcom requires tech firms to create crisis response plans
- Supermicro plans $7 billion financing to fund AI server orders
BioTelemetry, Inc. Reports Third Quarter 2020 Financial Results
October 29, 2020 4:05 PM EDTMALVERN, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended September 30, 2020.
Quarter Highlights
Recognized quarterly total revenue of $114.7 millionReached 3.0% year-over-year quarterly revenue growth, despite the impact of COVID-19Reported quarterly GAAP net income of $6.7 million, or 5.9% of total revenueRealized quarterly adjusted EBITDA of $30.6 million, or 26.7% of total revenueAcquired Remote Patient Monitoring... More